| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.06▲ | 3.07▲ | 3.10▼ | 3.18▼ | 3.04▲ |
| MA10 | 3.10▼ | 3.14▼ | 3.16▼ | 3.15▼ | 3.61▼ |
| MA20 | 3.17▼ | 3.19▼ | 3.18▼ | 3.05▲ | 4.39▼ |
| MA50 | 3.17▼ | 3.14▼ | 3.16▼ | 3.69▼ | N/A |
| MA100 | 3.14▼ | 3.11▼ | 3.01▲ | 4.42▼ | N/A |
| MA200 | 3.10▼ | 3.10▼ | 3.44▼ | 5.34▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.016▼ | -0.023▼ | -0.022▼ | 0.060▲ | N/A |
| RSI | 40.237▼ | 42.297▼ | 42.642▼ | 43.030▼ | N/A |
| STOCH | 16.766▼ | 9.150▼ | 10.738▼ | 55.805 | 14.131▼ |
| WILL %R | -78.431▼ | -79.630▼ | -79.630▼ | -59.677 | -88.041▼ |
| CCI | -54.799 | -86.098 | -112.447▼ | -63.918 | -83.484 |
|
Friday, December 13, 2019 02:25 PM
One theme that investors love in good times and in bad is dividend investing. One strategy that has been around for years is known as the Dogs of the Dow.
|
|
Friday, December 13, 2019 09:26 AM
The European Medicines Agency's advisory group CHMP has adopted a positive opinion recommending approval of Merck's (NYSE:MRK) Recarbio (imipenem/cilastatin/relebactam) for the treatment of ...
|
|
Thursday, December 12, 2019 04:32 AM
An exploratory analysis of the Phase 3 KEYNOTE-042 clinical trial evaluating Merck's (NYSE:MRK) Keytruda (pembrolizumab) as monotherapy versus chemo for the first-line treatment of metastatic ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 13/12/19 | 3.105 | 3.105 | 3.025 | 3.08 | 220,847 |
| 12/12/19 | 3.16 | 3.30 | 3.14 | 3.18 | 227,827 |
| 11/12/19 | 3.28 | 3.28 | 3.14 | 3.20 | 276,912 |
| 10/12/19 | 3.22 | 3.30 | 3.14 | 3.28 | 291,807 |
| 09/12/19 | 3.13 | 3.255 | 3.07 | 3.17 | 248,587 |
| 06/12/19 | 3.10 | 3.18 | 3.02 | 3.09 | 175,200 |
| 05/12/19 | 3.20 | 3.20 | 3.0538 | 3.12 | 189,566 |
| 04/12/19 | 3.11 | 3.19 | 2.92 | 3.17 | 377,300 |
| 03/12/19 | 3.12 | 3.22 | 2.86 | 3.00 | 591,300 |
| 02/12/19 | 3.38 | 3.38 | 3.12 | 3.17 | 362,800 |
|
|
||||
|
|
||||
|
|